Kalaris Therapeutics, Inc. (KLRS)
Market Closed
26 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (CM) Primary NASDAQ (NMS) $
1. 80
-0.07
-3.7433%
After Hours
$
+0.2 +11.1111% 2. 00
87.9M Market Cap
- P/E Ratio
- Div Yield
36,033 Volume
-1.75 Eps
$ 1.87
Previous Close Investors:
Want to track KLRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kalaris Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 13 | $75.01 | $23.53 | -$51.48 | -68.63% |
 Shawn M. McHugh WealthTrust Asset Management LLC | 23,604 | $116,053.64 | $44,375.52 | -$71,678.12 | -61.76% |
 Belena Vincetti Fortis Capital Advisors LLC | 40,000 | $231,200 | $78,000 | -$153,200 | -66.26% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 7 | $30.8 | $13.19 | -$17.61 | -57.18% |
 Raymond Debbane Siren, L.L.C. | 435,798 | $3.47M | $814,942.26 | -$2.65M | -76.5% |
2026 © Marketlog. All Rights Reserved.
